Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Mapk12em1/Cya
Common Name:
Mapk12-KO
Product ID:
S-KO-19494
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Mapk12-KO
Strain ID
KOCMP-29857-Mapk12-B6J-VB
Gene Name
Mapk12
Product ID
S-KO-19494
Gene Alias
Erk6; P38gamma; Prkm12; Sapk3
Background
C57BL/6JCya
NCBI ID
29857
Modification
Conventional knockout
Chromosome
15
Phenotype
MGI:1353438
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Mapk12em1/Cya mice (Catalog S-KO-19494) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000088827
NCBI RefSeq
NM_013871
Target Region
Exon 3
Size of Effective Region
~1.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Mapk12, also known as P38γ, is a member of the p38 MAPK family. It is involved in various cellular processes, such as cell proliferation, apoptosis, stress responses, and cancer development, and plays a crucial role in the regulation of the innate immune response [2,4,5]. Genetic models, like gene knockout mouse models, are valuable for studying its functions.

In osteoarthritis (OA), downregulation of Mapk12 was observed in H2O2-or IL-1β-stimulated cells and OA-related tissues. Over-expression of Mapk12 promoted cell proliferation and cartilage anabolism, inhibited cell senescence and cartilage catabolism, and relieved joint pain in relevant cell models and DMM mice, indicating its involvement in OA development through modulating chondrocyte senescence [1].

In cancer, pan-cancer analysis showed Mapk12 was overexpressed in multiple cancer types, and its upregulated mRNA expression was related to a worse prognosis. Knockdown of Mapk12 inhibited thyroid carcinoma cell proliferation, and its gene enrichment was related to cell proliferation and the tumor immune microenvironment. It was also closely related to immune checkpoint, microsatellite instability, and tumor mutational burden, affecting tumor sensitivity to immunotherapy [2].

In diffuse large B-cell lymphoma (DLBCL), high expression of Mapk12 was significantly correlated with shorter progression-free survival and overall survival, and was involved in the regulation of type II interferon production and lymphocyte proliferation [6].

In osteosarcoma, miR-187 inhibited tumor growth and invasion by directly targeting Mapk12 [7].

In ovine ovarian granulosa cells, high prolactin concentration promoted apoptosis and inhibited steroid hormone secretion by upregulating Mapk12 [3].

In conclusion, Mapk12 is a key regulator in multiple biological processes and diseases. Studies using gene-based models have revealed its role in OA, various cancers, and ovarian granulosa cell apoptosis. Understanding Mapk12 functions can provide potential therapeutic targets for these diseases.

References:
1. Geng, Nana, Xian, Menglin, Deng, Lin, Bai, Zhixun, Guo, Fengjin. 2024. Targeting the senescence-related genes MAPK12 and FOS to alleviate osteoarthritis. In Journal of orthopaedic translation, 47, 50-62. doi:10.1016/j.jot.2024.06.008. https://pubmed.ncbi.nlm.nih.gov/39007035/
2. Wang, Jinju, Song, Zhe, Ren, Li, Gu, Yi, Feng, Chao. 2022. Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA. In Oncology letters, 24, 445. doi:10.3892/ol.2022.13565. https://pubmed.ncbi.nlm.nih.gov/36420075/
3. Yang, Ruochen, Duan, Chunhui, Zhang, Shuo, Liu, Yueqin, Zhang, Yingjie. 2023. Prolactin Regulates Ovine Ovarian Granulosa Cell Apoptosis by Affecting the Expression of MAPK12 Gene. In International journal of molecular sciences, 24, . doi:10.3390/ijms241210269. https://pubmed.ncbi.nlm.nih.gov/37373417/
4. Escós, Alejandra, Diaz-Mora, Ester, Pattison, Michael, Ley, Steven C, Cuenda, Ana. 2023. p38γ and p38δ modulate innate immune response by regulating MEF2D activation. In eLife, 12, . doi:10.7554/eLife.86200. https://pubmed.ncbi.nlm.nih.gov/37458356/
5. Phan, Thuy, Zhang, Xu Hannah, Rosen, Steven, Melstrom, Laleh G. 2023. P38 kinase in gastrointestinal cancers. In Cancer gene therapy, 30, 1181-1189. doi:10.1038/s41417-023-00622-1. https://pubmed.ncbi.nlm.nih.gov/37248432/
6. Liu, Yue, Zhang, Han, Zhao, Shu, Zhang, Yue. 2024. A retrospective analysis of the clinicopathological features and prognostic value of MAPK12 protein expression in diffuse large B-cell lymphoma. In Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 26, 2966-2978. doi:10.1007/s12094-024-03515-3. https://pubmed.ncbi.nlm.nih.gov/38773060/
7. Cui, Chengliang, Shi, Xiaoyu. 2017. miR-187 inhibits tumor growth and invasion by directly targeting MAPK12 in osteosarcoma. In Experimental and therapeutic medicine, 14, 1045-1050. doi:10.3892/etm.2017.4624. https://pubmed.ncbi.nlm.nih.gov/28810556/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest